Johnson & Johnson (NYSE:JNJ) stock is a hot topic on Wednesday after the company proposed a $6.5 billion settlement over talc cancer lawsuits. Johnson & Johnson is seeking to bankrupt LTL Management as part of its settlement proposal. This is a subsidiary that was created for the sole purpose of absorbing the company’s talc cancer lawsuits. Previous attempts at this have been made but the court blocked it both times. This time around claimants will get to vote on the matter. Johnson & Johnson claims that th ...